Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr 4:11:2050313X231164268.
doi: 10.1177/2050313X231164268. eCollection 2023.

Topical steroid withdrawal syndrome in a mother and son: A case report

Affiliations
Case Reports

Topical steroid withdrawal syndrome in a mother and son: A case report

Aileen M Feschuk et al. SAGE Open Med Case Rep. .

Abstract

Topical corticosteroids are first-line treatment for many dermatoses, and are generally considered safe and effective. However, topical steroid withdrawal syndrome can result from use of topical corticosteroids, and this condition is not well-known among physicians. This article reports a mother and son whose presentations of topical steroid withdrawal syndrome following the discontinuation of prolonged, high-potency topical corticosteroid use were nearly identical. This report adds to the growing body of evidence that topical steroid withdrawal syndrome is its own entity, rather than an exacerbation of the underlying dermatosis, and adds to the few pediatric reports of topical steroid withdrawal syndrome. Management for both patients involved topical corticosteroid discontinuation; however, it took approximately 2 years before the majority of their topical steroid withdrawal syndrome manifestations resolved. Increased awareness surrounding this condition is essential to facilitate topical steroid withdrawal syndrome prevention and diagnosis and to decrease topical corticosteroid phobia and increase patient-physician trust.

Keywords: Case report; red skin syndrome; steroid phobia; topical steroid addiction; topical steroid withdrawal syndrome.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Timeline outlining the signs and symptoms of topical steroid withdrawal syndrome experienced by Patients-A and B.
Figure 2.
Figure 2.
Photographs of the face demonstrating topical steroid withdrawal syndrome and recovery in Patient-A (A1–A6) and Patient-B (B1 and B2).
Figure 3.
Figure 3.
Photographs of the body demonstrating topical steroid withdrawal syndrome and recovery in Patient-A (A1–A5) and Patient-B (B1 and B2). Photograph A & B1 displays a real-time comparison of topical steroid withdrawal syndrome in Patient-A (left) and Patient-B (right).

Similar articles

Cited by

References

    1. GOV.UK. Topical steroid withdrawal reactions: a review of the evidence, https://www.gov.uk/government/publications/topical-steroid-withdrawal-re... (accessed 2 January 2023).
    1. Hajar T, Leshem YA, Hanifin JM, et al.. A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol 2015; 72(3): 541.e2–549.e2. - PubMed
    1. Hwang J, Lio PA. Topical corticosteroid withdrawal (“steroid addiction”): an update of a systematic review. J Dermatol Treat 2022; 33(3): 1293–1298. - PubMed
    1. Government of Canada. Health Product InfoWatch, https://www.canada.ca/en/health-canada/services/drugs-health-products/me... (accessed 20 November 2022).
    1. Cotter C, Burton T, Proctor A, et al.. Topical steroid withdrawal syndrome: time to bridge the gap. Br J Dermatol 2022; 187(5): 780–781. - PubMed

Publication types

LinkOut - more resources